Molecular and phenotypic heterogeneity of metastatic prostate cancer

Cindy H. Chau, William D. Figg*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

4 Scopus citations


Metastatic prostate cancer remains a prevalent disease in the United States that requires detailed characterization of its pathobiology. In the December 2004 issue of Cancer Research, a comprehensive study by Shah et al. demonstrated that metastatic androgen-independent prostate cancer is a collective group of diseases even within the same patient. Understanding the molecular and phenotypic determinants of this heterogeneity is essential in assessing therapeutic outcomes in the management of prostate cancer progression.

Original languageEnglish
Pages (from-to)174-175
Number of pages2
JournalCancer Biology and Therapy
Issue number2
StatePublished - Feb 2005
Externally publishedYes


  • Cancer
  • Heterogeneity
  • Metastasis
  • Phenotype
  • Prostate


Dive into the research topics of 'Molecular and phenotypic heterogeneity of metastatic prostate cancer'. Together they form a unique fingerprint.

Cite this